ISPOR - PCN37 FDA NEW DRUGS APPROVAL FOR BREAST, COLORECTAL, PROSTATE AND LUNG CANCER AND HORIZON SCANNING OPPORTUNITY

PCN37 FDA NEW DRUGS APPROVAL FOR BREAST, COLORECTAL, PROSTATE AND LUNG CANCER AND HORIZON SCANNING OPPORTUNITY

Abstract

Authors

M.R.C. Nobre T. Ribeiro A. Ribeiro

Full Text Cite This Article

Back to Volume 19, Supplemental S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now